We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Name | Symbol | Market | Type |
|---|---|---|---|
| Bayer Aktiengesellschaft (PK) | USOTC:BAYRY | OTCMarkets | Depository Receipt |
| Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.24 | 3.26% | 7.60 | 7.60 | 7.64 | 7.674 | 7.53 | 7.64 | 2,607,824 | 21:00:01 |
From May 2019 to May 2024
By Nathan Allen
Bayer AG (BAYN.XE) said Friday that it will comply with a mediation order from a California judge, but it will continue to defend its products in court.
California judge Vince Chhabria, who is overseeing the litigation alleging Bayer's glyphosate-based weedkillers cause cancer, on Thursday canceled a trial set for late May and ordered confidential mediation between the company and the plaintiffs' lawyers.
Bayer said it accepted the order in good faith but reaffirmed its belief in glyphosate's safety record.
The German chemical and pharmaceutical company said it will remain focused on defending the products in a series of ongoing court cases, including appeals and post-trial proceedings.
Write to Nathan Allen at nathan.allen@dowjones.com
(END) Dow Jones Newswires
April 12, 2019 03:52 ET (07:52 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
1 Year Bayer Aktiengesellschaft (PK) Chart |
1 Month Bayer Aktiengesellschaft (PK) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
